BRCA1 and ovarian cancer: Notably, similar to the BRCA1-methylation-positive patients with breast and ovarian cancers, miR-155-5p was significantly higher in the BRCA1-methylated carriers compared to age-matched controls (p = 0.0418) (Figure 6A).